Advertisement

Topics

FDA approval for Ibrance in men with breast cancer sets precedent for use of real-world evidence

07:58 EDT 14 May 2019 | Pharmaceutical Technology

On 4 April the US Food and Drug Administration (FDA) announced its extension of the indication of Ibrance (palbociclib) in...
Read More...

The post FDA approval for Ibrance in men with breast cancer sets precedent for use of real-world evidence appeared first on Pharmaceutical Technology.

Original Article: FDA approval for Ibrance in men with breast cancer sets precedent for use of real-world evidence

NEXT ARTICLE

More From BioPortfolio on "FDA approval for Ibrance in men with breast cancer sets precedent for use of real-world evidence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...